NCT07451028

Brief Summary

Dysphagia is a frequent complication following stroke, with an estimated prevalence of 42%. One training modality which have been implemented in both hospitals and municipalities for alleviating dysphagia are oral neuromuscular training devices. These devices are hand-held acrylic devices which are inserted between the lips and teeth by the patient or an assistant and pulled forward against lip pressure. According to the developers of one of these devices coined IQoro, the training strengthens the orofacial and pharyngeal muscles. One of recent studies by the developer of IQoro, have demonstrated a positive effect of IQoro in improving swallowing function and reducing clinical signs of aspiration among older people in intermediate care. However, aspiration risk was based on unblinded subjective water swallowing tests, and findings may therefore be biased. Additionally, it should be considered that the study was a cluster-randomized study, in which the intervention was performed in some care units, and the usual care was performed in other care units. Since usual care is not described in detail, results in favor of IQoro may also be due to differences in the usual care practice between care units. Focusing on individuals with stroke, only observational studies have been carried out. These studies have shown functional improvements in all four quadrants of the mouth, improved lip strength, and improved swallowing capacity. However, observational studies suffer from the inherent limitation that it is not possible to establish whether training with IQoro is actually the cause of these improvements. The present research group recently published a small Randomized Controlled Trial (RCT), investigating the effectiveness of IQoro on swallowing function and decannulation in a very selective population of patients with cuffed tracheostomies due to severe acquired brain injury . Here, 22 subjects were randomized to either usual care, or usual care plus IQoro training as an add-on. In the study, there was no effect of IQoro in either time until decannulation, or swallowing function (as the implicit mechanism of action), compared with usual care. Patients with cuffed tracheostomy tubes are a very selective patient group, and results may not be generalized to a broader group of patients with post-stroke dysphagia. Based on this, more high-quality clinical trials with IQoro, on a broader population of patients with dysphagia admitted for neurorehabilitation is warranted, in order to clarify whether training with IQoro have an effect on swallowing. Aim and hypothesis The aim of this study is to investigate the effectiveness of oral neuromuscular training with IQoro on swallowing function in patients with dysphagia due to stroke. The hypothesis is that patients will have improved swallowing function because of training with IQoro as an add-on to usual care, compared with patients who only receive usual care. Study design An assessor-blinded randomized controlled trial. Study participants will be randomly assigned to either the IQoro (intervention group) or usual care (control group). The trial will be conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and approved by the Danish National Medical Research Ethics Committee

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
19mo left

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Mar 2026Dec 2027

First Submitted

Initial submission to the registry

February 27, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 5, 2026

Completed
22 days until next milestone

Study Start

First participant enrolled

March 27, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 10, 2026

Status Verified

December 1, 2025

Enrollment Period

1.8 years

First QC Date

February 27, 2026

Last Update Submit

March 6, 2026

Conditions

Keywords

DysphagiaStrokeOral neuromuscular training

Outcome Measures

Primary Outcomes (1)

  • McGill Ingestive Skills Assessment

    MISA is a standardized and validated assessment tool for quantifying degree of dysphagia. MISA consist of 36 items divided in four subscales: Positioning, Self-feeding skills, liquid ingestion, and solid ingestion. Total score ranges from 36 to 108, with higher score representing better swallowing function.

    From enrollment to the end of treatment at four weeks

Secondary Outcomes (2)

  • Iowa Oral Performance Instrument (IOPI)

    From enrollment to the end of treatment at four weeks

  • Dysphagia Handicap Index (DHI

    From enrollment to three months follow-up after the intervention

Study Arms (2)

IQoro

EXPERIMENTAL

IQoro training as an add-on to usual care

Device: IQoroBehavioral: Usual Care

Control

ACTIVE COMPARATOR

Usual care

Behavioral: Usual Care

Interventions

IQoroDEVICE

Training with IQoro according to instructions for use

IQoro
Usual CareBEHAVIORAL

Usual care for dysphagia, diet modification, swallowing exercises, posture

ControlIQoro

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First-ever stroke
  • Dysphagia assessed with the FOTT-SAS
  • Age ≥ 18 years

You may not qualify if:

  • Tracheostomy tube
  • Admitted for short-term evaluation
  • Lack of ability to cooperate with mouth closure
  • Contraindications for using IQoro

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hammel neurorehabilitation centre and university research clinic

Hammel, Jutland, 8450, Denmark

Location

MeSH Terms

Conditions

Deglutition DisordersStroke

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Jesper Fabricius, PhD

    Hammel Neurorehabilitation Centre and University Research Clinic & Department of clinical medicine, Aarhus University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jesper Fabricius, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2026

First Posted

March 5, 2026

Study Start

March 27, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

March 10, 2026

Record last verified: 2025-12

Locations